comparemela.com

Latest Breaking News On - Benitec biopharma inc - Page 6 : comparemela.com

Benitec Biopharma (NASDAQ:BNTC) Price Target Raised to $6 50

Benitec Biopharma (NASDAQ:BNTC – Free Report) had its price target raised by JMP Securities to $6.50 in a research report released on Tuesday morning, Marketbeat reports. They currently have a market outperform rating on the biotechnology company’s stock. Benitec Biopharma Trading Down 1.6 % Shares of BNTC stock opened at $3.02 on Tuesday. The company […]

Benitec Biopharma (NASDAQ:BNTC) Price Target Raised to $6 50

Benitec Biopharma (NASDAQ:BNTC – Free Report) had its price objective upped by JMP Securities to $6.50 in a research report report published on Tuesday morning, MarketBeat reports. They currently have a market outperform rating on the biotechnology company’s stock. Benitec Biopharma Stock Performance Shares of BNTC stock opened at $3.07 on Tuesday. The firm’s 50 […]

Benitec Biopharma : Material Event - Form 8-K -September 29, 2023 at 10:53 am EDT

JMP Securities Increases Benitec Biopharma (NASDAQ:BNTC) Price Target to $6 50

JMP Securities Increases Benitec Biopharma (NASDAQ:BNTC) Price Target to $6 50
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Head to Head Review: Benitec Biopharma (NASDAQ:BNTC) and LumiraDx (NASDAQ:LMDX)

Benitec Biopharma (NASDAQ:BNTC – Get Free Report) and LumiraDx (NASDAQ:LMDX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, institutional ownership and risk. Institutional and Insider Ownership 9.6% of LumiraDx shares […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.